| Autor: |
Schepers, K., Mouchet, F., Dirix, V., De Schutter, I., Jotzo, K., Verscheure, V., Geurts, P., Singh, M., Van Vooren, J. P., Mascart, F. |
| Zdroj: |
Clinical and Vaccine Immunology (formerly CDLI); December 2013, Vol. 21 Issue: 2 p111-118, 8p |
| Abstrakt: |
ABSTRACTThe diagnosis of childhood active tuberculosis (aTB) and latent Mycobacterium tuberculosis(M. tuberculosis) infection (LTBI) remains a challenge, and the replacement of tuberculin skin tests (TST) with commercialized gamma interferon (IFN-?) release assays (IGRA) is not currently recommended. Two hundred sixty-six children between 1 month and 15 years of age, 214 of whom were at risk of recent M. tuberculosisinfection and 51 who were included as controls, were prospectively enrolled in our study. According to the results of a clinical evaluation, TST, chest X ray, and microbiological assessment, each children was classified as noninfected, having LTBI, or having aTB. Long-incubation-time purified protein derivative (PPD), ESAT-6, and CFP-10 IGRA were performed and evaluated for their accuracy in correctly classifying the children. Whereas both TST and PPD IGRA were suboptimal for detecting aTB, combining the CFP-10 IGRA with a TST or with a PPD IGRA allowed us to detect all the children with aTB with a specificity of 96% for children who were positive for the CFP-10 IGRA. Moreover, the combination of the CFP-10 IGRA and PPD IGRA detected 96% of children who were eventually classified as having LTBI, but a strong IFN-? response to CFP-10 (defined as >500 pg/ml) was highly suggestive of aTB, at least among the children who were <3 years old. The use of long-incubation-time CFP-10 IGRA and PPD IGRA should help clinicians to quickly identify aTB or LTBI in young children. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
